These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15090282)

  • 21. Consumers' reports on the health effects of direct-to-consumer drug advertising.
    Weissman JS; Blumenthal D; Silk AJ; Zapert K; Newman M; Leitman R
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-82-95. PubMed ID: 14527237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct-to-consumer advertising and the patient-physician relationship.
    Shah MB; Bentley JP; McCaffrey DJ; Kolassa EM
    Res Social Adm Pharm; 2005 Jun; 1(2):211-30. PubMed ID: 17138475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of direct-to-consumer advertising on prescription drug use by older adults.
    Datti B; Carter MW
    Drugs Aging; 2006; 23(1):71-81. PubMed ID: 16492071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Models of physician-patient relationships in pharmaceutical direct-to-consumer advertising and consumer interviews.
    Arney J; Lewin B
    Qual Health Res; 2013 Jul; 23(7):937-50. PubMed ID: 23645149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physician switching after drug request refusal.
    Lee D; Begley CE
    Health Mark Q; 2011 Oct; 28(4):304-16. PubMed ID: 22054027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television.
    Macias W; Pashupati K; Lewis LS
    Health Commun; 2007; 22(3):241-52. PubMed ID: 17967146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing.
    Spence MM; Teleki SS; Cheetham TC; Schweitzer SO; Millares M
    Med Care Res Rev; 2005 Oct; 62(5):544-59. PubMed ID: 16177457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW; Bang HK
    Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct-to-consumer advertising of prescription drugs.
    Frosch DL; Grande D
    LDI Issue Brief; 2010; 15(3):1-4. PubMed ID: 20469541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
    Mintzes B; Barer M; Lexchin J; Bassett KL
    Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct-to-consumer advertising for urological pharmaceuticals: a cross-sectional analysis of print media.
    Folsom C; Fesperman SF; Tojuola B; Sultan S; Dahm P
    Urology; 2010 May; 75(5):1029-33. PubMed ID: 20080293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug information-seeking intention and behavior after exposure to direct-to-consumer advertisement of prescription drugs.
    Liu Y; Doucette WR; Farris KB; Nayakankuppam D
    Res Social Adm Pharm; 2005 Jun; 1(2):251-69. PubMed ID: 17138477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health literacy knowledge among direct-to-consumer pharmaceutical advertising professionals.
    Mackert M
    Health Commun; 2011 Sep; 26(6):525-33. PubMed ID: 21469006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Rosenthal M
    J Health Serv Res Policy; 2004 Jan; 9(1):39-42; discussion 41-2. PubMed ID: 15006239
    [No Abstract]   [Full Text] [Related]  

  • 35. Direct-to-consumer advertising of prescription medication in New Zealand.
    Every-Palmer S; Duggal R; Menkes DB
    N Z Med J; 2014 Aug; 127(1401):102-10. PubMed ID: 25225761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications.
    Viale PH; Sanchez Yamamoto D
    Oncol Nurs Forum; 2004 Jul; 31(4):777-83. PubMed ID: 15252431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct-to-consumer advertising under the radar: the need for realistic drugs policy in Australia.
    Mackenzie FJ; Jordens CF; Ankeny RA; McPhee J; Kerridge IH
    Intern Med J; 2007 Apr; 37(4):224-8. PubMed ID: 17388861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of pharmaceutical direct advertising: opportunities and obstructions.
    Pinto MB; Pinto JK; Barber JC
    Health Mark Q; 1998; 15(4):89-101. PubMed ID: 10185455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The past, present, and future of direct-to-consumer prescription drug advertising.
    Perri M; Shinde S; Banavali R
    Clin Ther; 1999 Oct; 21(10):1798-811; discussion 1797. PubMed ID: 10566574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct-to-consumer advertising.
    Haddy FJ
    Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(3):38-9. PubMed ID: 20690556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.